United Parcel Service, Inc. (NYSE: UPS) Healthcare reported new facilities and global expansion that is designed to bring unprecedented capabilities to global healthcare logistics customers. “Our decades of experience create the perfect foundation for continued investment in capabilities and infrastructure around the world,” said Chief Sales and Solutions Officer and Executive Vice President, UPS Global Healthcare Kate Gutmann. “UPS Healthcare is on a mission to provide our customers with even higher performance, greater cost efficiencies, and more sustainable shipping options.”
UPS has been successful with COVID-19 vaccine delivery as it creates long term value in the future delivery of new drugs, including biologics. Temperature controlled facilities are design to handle biologically derived drugs, such as vaccines at any temperature.
“We are building on our expertise and leadership displayed throughout the pandemic by continuing to develop new capabilities in cold chain logistics around the world,” said UPS Healthcare President Wes Wheeler. “With new facilities and capabilities, UPS Healthcare is better positioned to safely manage the growing number of temperature-sensitive biologic drugs, as well as cell and gene treatments currently in development.”
The post UPS Healthcare Continue to Expand Capabilities via Global Supply Chain first appeared on Financial Buzz .
For further details see:
UPS Healthcare Continue to Expand Capabilities via Global Supply Chain